Aspen Strikes Deal With India’s Laurus to Cut Cost of HIV Drugs
Metformin pills move through a sorting machine at a Laurus Labs Ltd. pharmaceutical plant in Visakhapatnam, Andhra Pradesh, India. (Photographer: Sara Hylton/Bloomberg)

Aspen Strikes Deal With India’s Laurus to Cut Cost of HIV Drugs

(Bloomberg) -- Aspen Pharmacare Holdings Ltd. agreed to a partnership with India’s Laurus Labs Ltd. to boost supply of active pharmaceutical ingredients that will help reduce the cost of HIV drugs.

The Durban-based company plans to license intellectual property rights owned by Laurus, executive Stavros Nicolaou said by phone on Friday. The Indian company will gain a trading entity in South Africa as part of the deal, he said.

The move will put Aspen in a better position to bid for government contracts as the country plans to scale up treatment to 6 million people, Nicolaou said. The deal was first reported by Business Day newspaper.

The shares rose 1.3% in early trade in Johannesburg.

©2019 Bloomberg L.P.

BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.